Historically, direct anti-hyperinflammatory strategies that attempt to block cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor (TNF), have been the main therapeutic pathway against sepsis. The gene discussed is IL1B; the disease is Sepsis.